/

Volastra Therapeutics

Develops cancer therapeutics targeting chromosomal instability in solid tumors.

BiotechnologyPharmaceuticals volastratx.com ↗

Company facts

Founded: 2019
Employees: 40
Headquarters: United States
Type: Private
Funding: Series B · $30M · 2025